CLDX logo

Celldex Therapeutics, Inc. (CLDX) Cash From Investing

Annual CFI:

-$290.13M-$184.35M(-174.27%)
December 31, 2024

Summary

  • As of today, CLDX annual cash from investing is -$290.13 million, with the most recent change of -$184.35 million (-174.27%) on December 31, 2024.
  • During the last 3 years, CLDX annual cash from investing has fallen by -$73.97 million (-34.22%).
  • CLDX annual cash from investing is now -422.57% below its all-time high of $89.94 million, reached on December 31, 2022.

Performance

CLDX Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCLDXcash flow metrics

Quarterly CFI:

$49.85M+$6.90M(+16.07%)
June 30, 2025

Summary

  • As of today, CLDX quarterly cash from investing is $49.85 million, with the most recent change of +$6.90 million (+16.07%) on June 30, 2025.
  • Over the past year, CLDX quarterly cash from investing has increased by +$96.57 million (+206.69%).
  • CLDX quarterly cash from investing is now -5.17% below its all-time high of $52.57 million, reached on March 31, 2023.

Performance

CLDX Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCLDXcash flow metrics

TTM CFI:

$164.60M+$96.57M(+141.95%)
June 30, 2025

Summary

  • As of today, CLDX TTM cash from investing is $164.60 million, with the most recent change of +$96.57 million (+141.95%) on June 30, 2025.
  • Over the past year, CLDX TTM cash from investing has increased by +$686.05 million (+131.57%).
  • CLDX TTM cash from investing is now at all-time high.

Performance

CLDX TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCLDXcash flow metrics

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

CLDX Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-174.3%+206.7%+131.6%
3Y3 Years-34.2%+97.2%+178.4%
5Y5 Years-1798.7%+145.9%+230.8%

CLDX Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-422.6%at low-5.2%+115.8%at high+131.6%
5Y5-Year-422.6%at low-5.2%+115.8%at high+131.6%
All-TimeAll-Time-422.6%at low-5.2%+115.8%at high+131.6%

CLDX Cash From Investing History

DateAnnualQuarterlyTTM
Jun 2025
-
$49.85M(+16.1%)
$164.60M(+142.0%)
Mar 2025
-
$42.95M(+78.6%)
$68.03M(+123.4%)
Dec 2024
-$290.13M(-174.3%)
$24.05M(-49.6%)
-$290.13M(+40.2%)
Sep 2024
-
$47.76M(+202.2%)
-$485.34M(+6.9%)
Jun 2024
-
-$46.72M(+85.2%)
-$521.45M(-10.1%)
Mar 2024
-
-$315.21M(-84.2%)
-$473.56M(-347.7%)
Dec 2023
-$105.78M(-217.6%)
-$171.16M(-1569.7%)
-$105.78M(-209.5%)
Sep 2023
-
$11.65M(+900.5%)
$96.59M(-10.6%)
Jun 2023
-
$1.16M(-97.8%)
$108.01M(-18.3%)
Mar 2023
-
$52.57M(+68.4%)
$132.13M(+46.9%)
Dec 2022
$89.94M(+141.6%)
$31.21M(+35.3%)
$89.94M(+126.1%)
Sep 2022
-
$23.07M(-8.8%)
$39.78M(+118.9%)
Jun 2022
-
$25.28M(+143.6%)
-$210.07M(+15.7%)
Mar 2022
-
$10.38M(+154.8%)
-$249.26M(-15.3%)
Dec 2021
-$216.16M(-120.1%)
-$18.94M(+91.6%)
-$216.16M(-29.9%)
Sep 2021
-
-$226.79M(-1530.2%)
-$166.36M(-1028.3%)
Jun 2021
-
-$13.91M(-132.0%)
$17.92M(+123.4%)
Mar 2021
-
$43.49M(+41.0%)
-$76.70M(+21.9%)
Dec 2020
-$98.22M(-675.0%)
$30.85M(+172.6%)
-$98.22M(+22.0%)
Sep 2020
-
-$42.51M(+60.8%)
-$125.85M(-61.7%)
Jun 2020
-
-$108.53M(-594.1%)
-$77.82M(-442.1%)
Mar 2020
-
$21.96M(+581.3%)
$22.75M(+33.2%)
Dec 2019
$17.08M(-42.7%)
$3.22M(-41.6%)
$17.08M(-0.7%)
Sep 2019
-
$5.52M(+169.3%)
$17.20M(+81.8%)
Jun 2019
-
-$7.96M(-148.8%)
$9.46M(-69.1%)
Mar 2019
-
$16.30M(+386.7%)
$30.62M(+2.7%)
Dec 2018
$29.82M(-35.8%)
$3.35M(+250.7%)
$29.82M(+127.8%)
Sep 2018
-
-$2.22M(-116.8%)
$13.09M(-22.9%)
Jun 2018
-
$13.19M(-14.8%)
$16.97M(-57.1%)
Mar 2018
-
$15.49M(+215.8%)
$39.56M(-14.9%)
Dec 2017
$46.47M(-32.6%)
-$13.38M(-903.7%)
$46.47M(-47.0%)
Sep 2017
-
$1.67M(-95.3%)
$87.63M(-13.1%)
Jun 2017
-
$35.78M(+59.7%)
$100.89M(+53.4%)
Mar 2017
-
$22.40M(-19.4%)
$65.77M(-4.6%)
Dec 2016
$68.91M(+237.3%)
$27.78M(+86.2%)
$68.91M(+15.1%)
Sep 2016
-
$14.92M(+2136.6%)
$59.87M(+4.6%)
Jun 2016
-
$667.00K(-97.4%)
$57.21M(+41.7%)
Mar 2016
-
$25.54M(+36.3%)
$40.38M(+180.5%)
Dec 2015
-$50.19M(-22.4%)
$18.74M(+52.9%)
-$50.19M(+2.0%)
Sep 2015
-
$12.26M(+175.9%)
-$51.24M(-12.7%)
Jun 2015
-
-$16.16M(+75.1%)
-$45.48M(-84.0%)
Mar 2015
-
-$65.03M(-467.5%)
-$24.72M(+39.7%)
Dec 2014
-$41.01M(+47.0%)
$17.70M(-1.8%)
-$41.01M(+43.5%)
Sep 2014
-
$18.02M(+291.8%)
-$72.53M(+14.7%)
Jun 2014
-
$4.60M(+105.7%)
-$84.99M(+24.2%)
Mar 2014
-
-$81.33M(-488.4%)
-$112.17M(-44.9%)
Dec 2013
-$77.42M(-356.0%)
-$13.82M(-348.7%)
-$77.42M(-13.6%)
Sep 2013
-
$5.56M(+124.6%)
-$68.14M(-0.6%)
Jun 2013
-
-$22.58M(+51.5%)
-$67.71M(-87.8%)
Mar 2013
-
-$46.58M(-926.6%)
-$36.05M(-112.3%)
Dec 2012
-$16.98M(-687.9%)
-$4.54M(-175.8%)
-$16.98M(-286.0%)
Sep 2012
-
$5.99M(-34.0%)
-$4.40M(>-9900.0%)
Jun 2012
-
$9.08M(+133.0%)
-$34.00K(+99.9%)
Mar 2012
-
-$27.51M(-442.0%)
-$34.93M(-1521.0%)
Dec 2011
-$2.15M(+86.7%)
$8.04M(-22.3%)
-$2.15M(+19.8%)
Sep 2011
-
$10.35M(+140.1%)
-$2.69M(+75.5%)
Jun 2011
-
-$25.82M(-590.0%)
-$10.96M(-226.6%)
Mar 2011
-
$5.27M(-29.8%)
-$3.36M(+79.2%)
Dec 2010
-$16.16M(-135.8%)
$7.51M(+261.5%)
-$16.16M(-176.9%)
Sep 2010
-
$2.08M(+111.4%)
$21.01M(+11.7%)
Jun 2010
-
-$18.22M(-141.7%)
$18.81M(-48.9%)
Mar 2010
-
-$7.54M(-116.9%)
$36.85M(-18.3%)
Dec 2009
$45.09M(+344.0%)
$44.68M(>+9900.0%)
$45.09M(+7355.5%)
Sep 2009
-
-$115.00K(+37.7%)
$604.80K(+514.0%)
Jun 2009
-
-$184.60K(-126.0%)
$98.50K(-22.7%)
Mar 2009
-
$709.60K(+264.3%)
$127.40K(-98.7%)
Dec 2008
$10.16M(+277.8%)
$194.80K(+131.4%)
$10.16M(+134.8%)
Sep 2008
-
-$621.30K(-299.0%)
$4.32M(-12.5%)
Jun 2008
-
-$155.70K(-101.5%)
$4.94M(-2.8%)
Mar 2008
-
$10.74M(+290.5%)
$5.08M(+189.0%)
Dec 2007
-$5.71M
-$5.64M(>-9900.0%)
-$5.71M(-48.9%)
DateAnnualQuarterlyTTM
Sep 2007
-
-$3300.00(+75.4%)
-$3.83M(+42.8%)
Jun 2007
-
-$13.40K(+77.1%)
-$6.71M(+22.7%)
Mar 2007
-
-$58.50K(+98.4%)
-$8.68M(+6.7%)
Dec 2006
-$9.31M(-328.3%)
-$3.76M(-30.7%)
-$9.31M(-46.1%)
Sep 2006
-
-$2.88M(-44.7%)
-$6.37M(-58.0%)
Jun 2006
-
-$1.99M(-190.5%)
-$4.03M(-61.4%)
Mar 2006
-
-$684.40K(+16.9%)
-$2.50M(-15.0%)
Dec 2005
-$2.17M(-31.2%)
-$823.50K(-53.3%)
-$2.17M(-51.1%)
Sep 2005
-
-$537.30K(-18.3%)
-$1.44M(+30.4%)
Jun 2005
-
-$454.20K(-26.6%)
-$2.07M(-16.8%)
Mar 2005
-
-$358.70K(-304.9%)
-$1.77M(-6.9%)
Dec 2004
-$1.66M(+25.0%)
-$88.60K(+92.4%)
-$1.66M(-12.9%)
Sep 2004
-
-$1.17M(-644.8%)
-$1.47M(-322.5%)
Jun 2004
-
-$156.70K(+35.9%)
-$347.40K(-18.1%)
Mar 2004
-
-$244.30K(-343.1%)
-$294.10K(+86.7%)
Dec 2003
-$2.21M(-162.9%)
$100.50K(+314.3%)
-$2.21M(+12.8%)
Sep 2003
-
-$46.90K(+54.6%)
-$2.53M(+4.1%)
Jun 2003
-
-$103.40K(+95.2%)
-$2.64M(+4.3%)
Mar 2003
-
-$2.16M(-869.2%)
-$2.76M(-228.7%)
Dec 2002
-$840.60K(-8.4%)
-$222.90K(-42.4%)
-$840.60K(-4.2%)
Sep 2002
-
-$156.50K(+30.0%)
-$807.00K(+12.9%)
Jun 2002
-
-$223.50K(+6.0%)
-$926.10K(-0.3%)
Mar 2002
-
-$237.70K(-25.6%)
-$923.50K(-19.1%)
Dec 2001
-$775.40K(+19.7%)
-$189.30K(+31.3%)
-$775.40K(+45.2%)
Sep 2001
-
-$275.60K(-24.8%)
-$1.41M(-12.2%)
Jun 2001
-
-$220.90K(-146.5%)
-$1.26M(-9.3%)
Mar 2001
-
-$89.60K(+89.2%)
-$1.15M(-19.4%)
Dec 2000
-$966.20K(-129.6%)
-$828.20K(-577.2%)
-$966.20K(+16.7%)
Sep 2000
-
-$122.30K(-7.3%)
-$1.16M(-14.7%)
Jun 2000
-
-$114.00K(-216.0%)
-$1.01M(+3.3%)
Mar 2000
-
$98.30K(+109.6%)
-$1.04M(-132.0%)
Dec 1999
$3.27M(-57.1%)
-$1.02M(-3939.5%)
$3.27M(-54.0%)
Sep 1999
-
$26.60K(+117.9%)
$7.10M(-44.5%)
Jun 1999
-
-$148.30K(-103.4%)
$12.79M(+5.5%)
Mar 1999
-
$4.41M(+56.9%)
$12.13M(+59.1%)
Dec 1998
$7.63M(+406.7%)
$2.81M(-50.8%)
$7.63M(+61.8%)
Sep 1998
-
$5.72M(+805.7%)
$4.71M(+526.7%)
Jun 1998
-
-$810.50K(-758.6%)
-$1.10M(-275.3%)
Mar 1998
-
-$94.40K(+5.6%)
-$294.40K(-119.6%)
Dec 1997
$1.50M(+710.3%)
-$100.00K(0.0%)
$1.50M(-11.8%)
Sep 1997
-
-$100.00K(>-9900.0%)
$1.70M(-10.5%)
Jun 1997
-
$0.00(-100.0%)
$1.90M(+11.8%)
Mar 1997
-
$1.70M(+1600.0%)
$1.70M(+950.0%)
Dec 1996
-$246.60K(-104.2%)
$100.00K(0.0%)
-$200.00K(+87.5%)
Sep 1996
-
$100.00K(+150.0%)
-$1.60M(+42.9%)
Jun 1996
-
-$200.00K(0.0%)
-$2.80M(-3.7%)
Mar 1996
-
-$200.00K(+84.6%)
-$2.70M(-145.8%)
Dec 1995
$5.91M(-49.0%)
-$1.30M(-18.2%)
$5.90M(-72.0%)
Sep 1995
-
-$1.10M(-1000.0%)
$21.10M(-4.1%)
Jun 1995
-
-$100.00K(-101.2%)
$22.00M(+5.3%)
Mar 1995
-
$8.40M(-39.6%)
$20.90M(+80.2%)
Dec 1994
$11.58M(-1.9%)
$13.90M(+7050.0%)
$11.60M(+11.5%)
Sep 1994
-
-$200.00K(+83.3%)
$10.40M(+1.0%)
Jun 1994
-
-$1.20M(-33.3%)
$10.30M(-8.0%)
Mar 1994
-
-$900.00K(-107.1%)
$11.20M(-5.1%)
Dec 1993
$11.80M(+427.8%)
$12.70M(+4333.3%)
$11.80M(+1411.1%)
Sep 1993
-
-$300.00K(0.0%)
-$900.00K(+10.0%)
Jun 1993
-
-$300.00K(0.0%)
-$1.00M(0.0%)
Mar 1993
-
-$300.00K(+25.0%)
-$1.00M(+16.7%)
Dec 1992
-$3.60M(-414.3%)
-
-
Oct 1992
-
-$400.00K(-33.3%)
-$1.20M(-33.3%)
Jul 1992
-
-$300.00K(0.0%)
-$900.00K(-28.6%)
Apr 1992
-
-$300.00K(-50.0%)
-$700.00K(-40.0%)
Apr 1992
-$700.00K(-75.0%)
-
-
Jan 1992
-
-$200.00K(-100.0%)
-$500.00K(0.0%)
Oct 1991
-
-$100.00K(0.0%)
-$500.00K(-25.0%)
Jul 1991
-
-$100.00K(0.0%)
-$400.00K(0.0%)
Apr 1991
-$400.00K(+55.6%)
-$100.00K(+50.0%)
-$400.00K(-33.3%)
Jan 1991
-
-$200.00K(>-9900.0%)
-$300.00K(-200.0%)
Oct 1990
-
$0.00(+100.0%)
-$100.00K(0.0%)
Jul 1990
-
-$100.00K
-$100.00K
Apr 1990
-$900.00K
-
-

FAQ

  • What is Celldex Therapeutics, Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for Celldex Therapeutics, Inc.?
  • What is Celldex Therapeutics, Inc. annual cash from investing year-on-year change?
  • What is Celldex Therapeutics, Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Celldex Therapeutics, Inc.?
  • What is Celldex Therapeutics, Inc. quarterly cash from investing year-on-year change?
  • What is Celldex Therapeutics, Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for Celldex Therapeutics, Inc.?
  • What is Celldex Therapeutics, Inc. TTM cash from investing year-on-year change?

What is Celldex Therapeutics, Inc. annual cash from investing?

The current annual cash from investing of CLDX is -$290.13M

What is the all-time high annual cash from investing for Celldex Therapeutics, Inc.?

Celldex Therapeutics, Inc. all-time high annual cash from investing is $89.94M

What is Celldex Therapeutics, Inc. annual cash from investing year-on-year change?

Over the past year, CLDX annual cash from investing has changed by -$184.35M (-174.27%)

What is Celldex Therapeutics, Inc. quarterly cash from investing?

The current quarterly cash from investing of CLDX is $49.85M

What is the all-time high quarterly cash from investing for Celldex Therapeutics, Inc.?

Celldex Therapeutics, Inc. all-time high quarterly cash from investing is $52.57M

What is Celldex Therapeutics, Inc. quarterly cash from investing year-on-year change?

Over the past year, CLDX quarterly cash from investing has changed by +$96.57M (+206.69%)

What is Celldex Therapeutics, Inc. TTM cash from investing?

The current TTM cash from investing of CLDX is $164.60M

What is the all-time high TTM cash from investing for Celldex Therapeutics, Inc.?

Celldex Therapeutics, Inc. all-time high TTM cash from investing is $164.60M

What is Celldex Therapeutics, Inc. TTM cash from investing year-on-year change?

Over the past year, CLDX TTM cash from investing has changed by +$686.05M (+131.57%)
On this page